Notice of Investor Relations Event - Participation in Korea Investment & Securities NDR
- NDR for domestic institutional investors on May 7, 2026 in Seoul
- Sponsored by Korea Investment & Securities, 1:1 in-person meetings
- Q1 2026 business update and Q&A session
- IR materials to be posted on the company website prior to the event
ADVERTISEMENT (250px+)
KOSPI Filing Information
- Filing: Corporate Briefing (IR) Holding (Notice Disclosure)
- Company: Hanmi Pharm (128940)
- Submission: Hanmi Pharm. Co., Ltd.
- Receipt: 04-30-2026
- Under KRX KOSPI Market Division